An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 1 - 25 of 178

  1. The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumonia

    • International Journal of Antimicrobial Agents
    • Background The effect of systemic treatment of ventilator-associated pneumonia (VAP) with telavancin, a semisynthetic lipoglycopeptide with good penetration in vitro biofilms, has not been tested in vivo during mechanical ventilation.

      • Bacterial pathogens
      • Staphylococcus aureus
  2. Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms

    • International Journal of Antimicrobial Agents
    • Background: Daptomycin (DAP) is indicated for difficult-to-treat Gram-positive infections, especially those caused by methicillin-resistant S. aureus (MRSA). Exposure of S.

      • Bacterial pathogens
      • Staphylococcus aureus
  3. Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus

    • International Journal of Antimicrobial Agents
    • Background The anti-biofilm efficacy of dalbavancin has been evaluated in static models. Using an in vitro pharmacokinetic/pharmacodynamic model, we evaluated the comparative activity of dalbavancin alone and with rifampicin against biofilm-embedded methicillin-resistant S. aureus (MRSA). Methods Two MRSA strains (HUB-4/HUB-5) were evaluated with the Calgary Device System and the dynamic CDC-Biofilm Reactor over 144 h.

      • Bacterial pathogens
      • Staphylococcus aureus
  4. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia

    • International Journal of Antimicrobial Agents
    • Background: Few studies have evaluated the use of ceftriaxone (CRO) in the treatment of methicillin-sensitive Staphylococcus aureus (MSSA) infections. The purpose of this study was to compare the safety and efficacy of CRO versus cefazolin (CFZ) for patients with MSSA bacteremia. Methods: This was a multi-center, single health-system retrospective study.

      • Bacterial pathogens
      • Staphylococcus aureus
  5. Emergence of methicillin resistant Staphylococcus epidermidis resistant to linezolid: activity of ceftaroline versus ceftobiprole in a French University French Hospital

    • International Journal of Antimicrobial Agents
    • Respective activities of ceftaroline and ceftobiprole were reported against staphylococci isolated in 2008, 2013, 2017, 2018 from bacteraemia and lower respiratory tract infections in England and Ireland.1 Methicillin-susceptible staphylococci were susceptible to both molecules. The behavior of methicillin-resistant staphylococci was dependent on the bacterial species. Only 1/424 (0.23%) methicillin-resistant S.

      • Bacterial pathogens
      • Staphylococcus aureus
  6. Genomic Characterisation of CC398 MRSA Causing Severe Disease in Australia

    • International Journal of Antimicrobial Agents
    • Complex (CC) 398 livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) has been reported worldwide in a variety of food-animal species.

      • Bacterial pathogens
      • Staphylococcus aureus
  7. MRSA Surveillance Programmes Worldwide: Moving towards a harmonised international approach

    • International Journal of Antimicrobial Agents
    • Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and propose a framework for harmonisation of MRSA surveillance.

      • Bacterial pathogens
      • Staphylococcus aureus
  8. Genotyping of methicillin-resistant Staphylococcus aureus isolates causing invasive infections using spa typing and their correlation with antibiotic susceptibility

    • International Journal of Antimicrobial Agents
    • The antibiotic susceptibility patterns were correlated with particular spa types, and this correlation would help physicians select appropriate antibiotics for treatment of invasive MRSA infections. The aim of this research was to investigate invasive methicillin-resistant Staphylococcus aureus (MRSA) through delineatingthe molecular typing results and correlating them with antibiotic susceptibility.

      • Bacterial pathogens
      • Staphylococcus aureus
  9. A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression

    • International Journal of Antimicrobial Agents
    • Toxoplasmosis is a major health issue worldwide especially for immune-deficient individuals and the offspring of newly infected mothers. It is caused by a unicellular intracellular parasite called Toxoplasma gondii. Although the drugs commonly used to treat toxoplasmosis are efficient, they present serious side effects and adverse events are common. Therefore, there is a need for the discovery of new compounds with potent anti-T. gondii activity.

      • Parasites
      • Toxoplasma gondii
  10. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  11. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis

    • International Journal of Antimicrobial Agents
      • Bacterial pathogens
      • Staphylococcus aureus
  12. Evaluation of early antibiotic use in patients with non‐severe COVID‐19 without bacterial infection

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  13. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  14. High dose ivermectin for the early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof of concept clinical trial

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  15. Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China

    • International Journal of Antimicrobial Agents
    • Author(s): Jing Wang, Yue Jiang, Ruo-Yun Ji, Zhen-Yu Wang, Meng-Jun Lu, Han Wu, Cai-Yue Mei, Qiu-Chun Li, Xinan Jiao Colistin and tigecycline are regarded as the last-resort antibiotics for the treatment of serious clinical infections caused by enxtensively drug-resistant Gram-negative organisms, particularly carbapenemase-producing Enterobacteriaceae and Acinetobacter isolates, but the emergence and spread of plasmid-mediated colistin (mcr) or tigecycline [tet(X) and tmexCD1-toprJ1] res

      • Bacterial pathogens
      • Salmonella
  16. Corrigendum to “Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli” [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]

    • International Journal of Antimicrobial Agents
    • Author(s): Patrick McKernan, Benjamin Cassidy, Alexis Woodward, James Battiste, Douglas Drevets, Roger Harrison

      • Listeria monocytogenes
      • Bacterial pathogens
  17. Circulation of multidrug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019.

    • International Journal of Antimicrobial Agents
    • Author(s): Albert Moreno-Mingorance, Paula Espinal, Virginia Rodriguez, Lidia Goterris, Anna Fàbrega, Judit Serra-Pladevall, M. Jesús Barberà, M. Alberny, Héctor Martín-González, Thais Cornejo-Sánchez, Mayuli Armas, Alba Mir-Cros, Alex Raventós, Belén Viñado, T. Pumarola, M.N. Larrosa, Juan José González-López

      • Shigella
      • Bacterial pathogens
  18. Molecular genetic characteristic of mcr-9-harbouring Salmonella enterica Serotype Typhimurium isolated from raw milk: mcr-9 in Salmonella enterica Serotype Typhimurium from raw milk

    • International Journal of Antimicrobial Agents
    • Author(s): Xiaoming Wang, Zhuoren Ling, Naiyan Sun, Yongshi Liu, Jinhu Huang, Liping Wang

      • Bacterial pathogens
      • Salmonella
  19. Anionic Phospholipid Expression as a Molecular Target in Listeria monocytogenes and Escherichia coli

    • International Journal of Antimicrobial Agents
    • Author(s): Patrick McKernan, Benjamin Cassidy, Alexis Woodward, James Battiste, Douglas Drevets, Roger Harrison

      • Listeria monocytogenes
      • Bacterial pathogens
  20. Adaptive laboratory evolution of Vibrio cholerae to doxycycline associated with spontaneous mutation

    • International Journal of Antimicrobial Agents
    • Author(s): Lekshmi Narendrakumar, Sivakumar Krishnankutty Chandrika, Sabu Thomas

      • Bacterial pathogens
      • Vibrio
  21. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

    • International Journal of Antimicrobial Agents
    • Author(s): Emre Kara, Kutay Demirkan, Serhat Unal

      • COVID-19
  22. Lactoferrin as potential preventative and adjunct treatment for COVID-19

    • International Journal of Antimicrobial Agents
    • Author(s): Raymond Chang, Tzi Bun Ng, Wei-Zen Sun

      • COVID-19
  23. Combating devastating COVID-19 by drug repurposing

    • International Journal of Antimicrobial Agents
    • Author(s): Ashish Yashwantrao Pawar

      • COVID-19
  24. COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

    • International Journal of Antimicrobial Agents
    • Author(s): Yang Song, Min Zhang, Ling Yin, Kunkun Wang, Yiyi Zhou, Mi Zhou, Yun Lu

      • COVID-19
  25. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

    • International Journal of Antimicrobial Agents
    • Author(s): Arianna Pani, Marinella Lauriola, Alessandra Romandini, Francesco Scaglione

      • COVID-19